More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice

Journal of Neuroscience Research

Volumn 88, Issue 9, 2010, Pages 2026-2034

  Yeung, Chung Man ^a   Lo, Amy C Y ^a   Cheung, Alvin K H ^a   Chung, Stephen S M ^a   Wong, David ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Animal model; Db db mouse; Ischemia; Reperfusion; Retina

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDEHYDE REDUCTASE; AQUAPORIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; RETINA ISCHEMIA; SWELLING; WILD TYPE;

ALDEHYDE REDUCTASE; ANIMALS; AQUAPORIN 4; BLOOD GLUCOSE; BRAIN; BRAIN ISCHEMIA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; RETINA; RETINAL DISEASES; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 77953481998     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22349     Document Type: Article

References (41)

1. Aasum E, Hafstad AD, Severson DL, Larsen TS. 2003. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52:434-441.
2. Anzawa R, Bernard M, Tamareille S, Baetz D, Confort-Gouny S, Gascard JP, Cozzone P, Feuvray D. 2006. Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice. Diabetologia 49:598-606.
3. Calcutt NA, Willars GB, Tomlinson DR. 1988. Axonal transport of choline acetyltransferase and 6-phosphofructokinase activities in genetically diabetic mice. Muscle Nerve 11:1206-1210.
4. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK. 2005. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119-3125.
5. Cheung AK, Lo AC, So KF, Chung SS, Chung SK. 2007. Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury. Exp Eye Res 85:608-616.
6. Chung SS, Chung SK. 2005. Aldose reductase in diabetic microvascular complications. Curr Drug Targets 6:475-486.
7. Clements RS Jr, Robison WG Jr, Cohen MP. 1998. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 12:28-33.
8. Da T, Verkman AS. 2004. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci 45:4477-4483.
9. Drel VR, Pacher P, Stevens MJ, Obrosova IG. 2006. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic Biol Med 40:1454-1465.
10. Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG. 2008. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. Int J Mol Med 21:667-676.
11. El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB. 2003. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 44:3135-3143.
12. +-ATPase activity. Am J Physiol Cell Physiol 282:C560-C566.
13. Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N. 2000. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care 23:1539-1544.
14. Ho EC, Lam KS, Chen YS, Yip JC, Arvindakshan M, Yamagishi S, Yagihashi S, Oates PJ, Ellery CA, Chung SS, Chung SK. 2006. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55:1946-1953.
15. Hurn PD, Macrae IM. 2000. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20:631-652.
16. Hwang YC, Kaneko M, Bakr S, Liao H, Lu Y, Lewis ER, Yan S, Ii S, Itakura M, Rui L, Skopicki H, Homma S, Schmidt AM, Oates PJ, Szabolcs M, Ramasamy R. 2004. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 18:1192-1199. (Pubitemid 39006881)
17. Iandiev I, Pannicke T, Hollborn M, Wiedemann P, Reichenbach A, Grimm C, Reme CE, Bringmann A. 2008. Localization of glial aquaporin-4 and Kir4.1 in the light-injured murine retina. Neurosci Lett 434:317-321.
18. Kodama H, Fujita M, Yamaguchi I. 1994. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/ KsJ-db/db) mice. Diabetologia 37:739-744. (Pubitemid 24247843)
19. Kowluru RA, Jirousek MR, Stramm L, Farid N, Engerman RL, Kern TS. 1998. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes 47:464-469.
20. Kumari R, Willing LB, Krady JK, Vannucci SJ, Simpson IA. 2007. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J Cereb Blood Flow Metab 27:710-718.
21. Li J, Patil RV, Verkman AS. 2002. Mildly abnormal retinal function in transgenic mice without Muller cell aquaporin-4 water channels. Invest Ophthalmol Vis Sci 43:573-579. (Pubitemid 34113244)
22. Lo AC, Chen AY, Hung VK, Yaw LP, Fung MK, Ho MC, Tsang MC, Chung SS, Chung SK. 2005. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cereb Blood Flow Metab 25:998-1011.
23. Lo AC, Cheung AK, Hung VK, Yeung CM, He QY, Chiu JF, Chung SS, Chung SK. 2007. Deletion of aldose reductase leads to protection against cerebral ischemic injury. J Cereb Blood Flow Metab 27:1496-1509.
24. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS. 2000. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6:159-163.
25. Martini SR, Kent TA. 2007. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab 27:435-451.
26. Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, Belloni AS. 1989. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 21:106-111.
27. Obrosova IG, Fathallah L. 2000. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Diabetologia 43:1048-1055.
28. Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ. 2002. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 16:123-125.
29. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ. 2003. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52:864-871.
30. Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA. 2005. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54:234-242.
31. Papadopoulos MC, Verkman AS. 2007. Aquaporin-4 and brain edema. Pediatr Nephrol 22:778-784.
32. Ramasamy R, Oates PJ, Schaefer S. 1997. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 46:292-300. (Pubitemid 27272264)
33. Ramasamy R, Liu H, Oates PJ, Schaefer S. 1999. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat. Cardiovasc Res 42:130-139.
34. Ribeiro Mde C, Hirt L, Bogousslavsky J, Regli L, Badaut J. 2006. Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res 83:1231-1240.
35. Roof RL, Hall ED. 2000. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 17:367-388.
36. Sharma K, McCue P, Dunn SR. 2003. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284:F1138-F1144.
37. Srivastava SK, Ramana KV, Bhatnagar A. 2005. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380-392.
38. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T, Maruno M, Kato A, Ohnishi T, Kohmura E, Tohyama M, Yoshimine T. 2000. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res 78:131-137.
39. Uehara K, Yamagishi S, Otsuki S, Chin S, Yagihashi S. 2004. Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice. Diabetes 53:3239-3247.
40. Vannucci SJ, Willing LB, Goto S, Alkayed NJ, Brucklacher RM, Wood TL, Towfighi J, Hurn PD, Simpson IA. 2001. Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab 21:52-60. (Pubitemid 32016839)
41. Watarai A, Nakashima E, Hamada Y, Watanabe G, Naruse K, Miwa K, Kobayashi Y, Kamiya H, Nakae M, Hamajima N, Sekido Y, Niwa T, Oiso Y, Nakamura J. 2006. Aldose reductase gene is associated with diabetic macroangiopathy in Japanese type 2 diabetic patients. Diabet Med 23:894-899.